Agios Pharmaceuticals Current Ratio 2012-2019 | AGIO

Agios Pharmaceuticals current ratio from 2012 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Agios Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-03-31 $0.56B $0.08B 6.89
2018-12-31 $0.61B $0.09B 6.56
2018-09-30 $0.70B $0.09B 8.21
2018-06-30 $0.75B $0.09B 8.88
2018-03-31 $0.80B $0.08B 10.75
2017-12-31 $0.45B $0.10B 4.69
2017-09-30 $0.53B $0.09B 6.00
2017-06-30 $0.61B $0.09B 6.46
2017-03-31 $0.51B $0.08B 6.15
2016-12-31 $0.56B $0.09B 6.33
2016-09-30 $0.60B $0.08B 7.70
2016-06-30 $0.48B $0.07B 7.20
2016-03-31 $0.33B $0.05B 7.31
2015-12-31 $0.34B $0.05B 6.38
2015-09-30 $0.37B $0.05B 7.47
2015-06-30 $0.39B $0.05B 8.63
2015-03-31 $0.36B $0.04B 10.01
2014-12-31 $0.36B $0.06B 5.89
2014-09-30 $0.25B $0.04B 7.06
2014-06-30 $0.25B $0.05B 5.49
2014-03-31 $0.17B $0.03B 5.06
2013-12-31 $0.17B $0.04B 4.60
2013-09-30 $0.20B $0.04B 5.32
2013-06-30 $0.10B $0.04B 2.77
2013-03-31 $0.00B $0.00B 0.00
2012-12-31 $0.00B $0.00B 0.00
2012-09-30 $0.00B $0.00B 0.00
2012-06-30 $0.00B $0.00B 0.00
2011-12-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.854B $0.094B
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. It discovers and develops therapeutics in the field of cancer metabolism and inborn errors of metabolism. The Company's products include AG-221, AG-120, enzyme glutaminase and AG-348. Agios Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $133.672B 25.95
Medtronic (MDT) Ireland $117.445B 17.17
Stryker (SYK) United States $68.767B 24.54
Boston Scientific (BSX) United States $51.857B 24.86
Baxter (BAX) United States $38.426B 24.22
Zimmer Biomet Holdings (ZBH) United States $23.740B 15.25
Smith & Nephew SNATS (SNN) United Kingdom $18.286B 0.00
ResMed (RMD) United States $16.069B 30.70
Canopy Growth (CGC) Canada $14.891B 0.00
Bio-Rad Laboratories (BIO) United States $8.726B 46.26
Aurora Cannabis (ACB) Canada $8.610B 84.90
Perrigo (PRGO) Ireland $6.742B 11.40
Hill-Rom Holdings (HRC) United States $6.410B 19.43
Insulet (PODD) United States $6.211B 452.52
GW Pharmaceuticals (GWPH) United Kingdom $5.395B 0.00
Haemonetics (HAE) United States $5.107B 41.90
ICU Medical (ICUI) United States $4.607B 27.49
Hutchison China MediTech (HCM) China $3.581B 0.00
NuVasive (NUVA) United States $3.197B 26.11
Neogen (NEOG) United States $3.035B 49.35
Quidel (QDEL) United States $2.215B 22.99
National Vision Holdings (EYE) United States $2.083B 44.38
Aphria (APHA) $1.662B 0.00
HEXO (HEXO) $1.463B 0.00
Cardiovascular Systems (CSII) United States $1.368B 785.40
Phibro Animal Health (PAHC) United States $1.179B 17.66
AtriCure (ATRC) United States $1.136B 0.00
VAREX IMAGING (VREX) United States $1.097B 23.29
NanoString Technologies (NSTG) United States $0.939B 0.00
Lantheus Holdings (LNTH) United States $0.929B 24.68
Omeros (OMER) United States $0.913B 0.00
MacroGenics (MGNX) United States $0.890B 0.00
PetIQ (PETQ) United States $0.812B 19.73
Eagle Pharmaceuticals (EGRX) United States $0.751B 21.07
Cerus (CERS) United States $0.743B 0.00
TG Therapeutics (TGTX) United States $0.594B 0.00
LeMaitre Vascular (LMAT) United States $0.534B 25.84
OraSure Technologies (OSUR) United States $0.524B 24.11
Surmodics (SRDX) United States $0.516B 74.96
Quanterix (QTRX) United States $0.500B 0.00
Meridian Bioscience (VIVO) United States $0.478B 14.62
Evolus (EOLS) United States $0.475B 0.00
BioLife Solutions (BLFS) United States $0.351B 109.94
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.314B 0.00
Utah Medical Products (UTMD) United States $0.303B 21.00
Vapotherm (VAPO) United States $0.289B 0.00
Rockwell Medical (RMTI) United States $0.282B 0.00
Zynex (ZYXI) United States $0.242B 25.07
Owens & Minor (OMI) United States $0.225B 4.76
Cytosorbents (CTSO) United States $0.223B 0.00
Bovie Medical (APYX) United States $0.206B 0.00
Chimerix (CMRX) United States $0.174B 0.00
Fonar (FONR) United States $0.135B 7.08
Chembio Diagnostics (CEMI) United States $0.132B 0.00
Surface Oncology (SURF) United States $0.110B 0.00
Female Health (VERU) United States $0.104B 0.00
InfuSystems Holdings (INFU) United States $0.098B 0.00
United-Guardian (UG) United States $0.092B 20.31
Neurotrope (NTRP) United States $0.092B 0.00
Insys Therapeutics (INSY) United States $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 21.67
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.044B 0.00
Senestech (SNES) United States $0.040B 0.00
GUARDION HEALTH (GHSI) United States $0.033B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.028B 0.00
BRAINSWAY LTD (BWAY) Israel $0.026B 0.00
Valeritas Holdings (VLRX) United States $0.022B 0.00
Myomo (MYO) United States $0.017B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.006B 4.54